
News|Articles|September 2, 2003
- Pharmaceutical Technology-09-02-2003
- Volume 27
- Issue 9
Counterfeiting, Compliance, and Controls
Author(s)Jill Wechsler
FDA and manufacturers seek to curb drug counterfeiting while legislators consider liberalizing drug importing policies to cut pharmaceutical costs.
Advertisement
Articles in this issue
almost 23 years ago
September 2003almost 23 years ago
In the Spotlight September 2003almost 23 years ago
September 2003almost 23 years ago
Disposable Filtration Lightens Cleaning and Validation Loadalmost 23 years ago
CROs Hoping for Research Burst in Second Half of 2003almost 23 years ago
Improved Blister Packaging Benefits Consumers, Caregivers, and Drug MakersAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Documentation Reliability Across Contractors: A Quality Systems Approach
3
What to Know About Regulations in June 2026
4
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
5




